Roivant Sciences Ltd.
Total Trades
177
Buys
3
Sells
120
Largest Trade
$1M+
Insiders
15
Institutional Funds
328
Inst. Value
$1M+
Activist Filings
42
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Venker Eric | COO | SELL | $500K+ | 60K | $11.89 | Aug 17, 2023 |
| Venker Eric | COO | SELL | $500K+ | 45K | $11.93 | Aug 8, 2023 |
| Venker Eric | COO | EXERCISE | $100K–$500K | 45K | $3.85 | Aug 8, 2023 |
| Kumar Rakhi | Chief Accounting O… | EXERCISE | $15K–$50K | 4K | $6.48 | Aug 4, 2023 |
| Kumar Rakhi | Chief Accounting O… | SELL | $15K–$50K | 4K | $12.00 | Aug 4, 2023 |
| Venker Eric | COO | EXERCISE | $500K+ | 195K | $3.85 | Aug 3, 2023 |
| Venker Eric | COO | SELL | $1M+ | 195K | $11.91 | Aug 3, 2023 |
| Venker Eric | COO | SELL | $1M+ | 126K | $10.91 | Jul 28, 2023 |
| Venker Eric | COO | EXERCISE | $100K–$500K | 126K | $3.85 | Jul 28, 2023 |
| Venker Eric | President & COO | SELL | $1M+ | 374K | $11.19 | Jul 25, 2023 |
| Venker Eric | President & COO | EXERCISE | $1M+ | 374K | $3.85 | Jul 25, 2023 |
| Kumar Rakhi | Chief Accounting O… | SELL | $1K–$15K | 635 | $12.00 | Jul 19, 2023 |
| Kumar Rakhi | Chief Accounting O… | EXERCISE | $1K–$15K | 635 | $6.48 | Jul 19, 2023 |
| VIKING GLOBAL INVESTORS LP | 10% Owner | SELL | $1M+ | 13.0M | $9.90 | Jun 26, 2023 |
| VIKING GLOBAL PERFORMANCE LLC | 10% Owner | SELL | $1M+ | 13.0M | $9.90 | Jun 26, 2023 |
| Sumitomo Chemical Co., Ltd. | 10% Owner | SELL | $1M+ | 15.1M | $8.60 | Jun 26, 2023 |
| Kumar Rakhi | Chief Accounting O… | SELL | $100K–$500K | 44K | $9.93 | Jun 14, 2023 |
| Kumar Rakhi | Chief Accounting O… | EXERCISE | $100K–$500K | 44K | $5.12 | Jun 14, 2023 |
| Venker Eric | President & COO | SELL | $1M+ | 300K | $9.91 | Jun 10, 2023 |
| Venker Eric | President & COO | EXERCISE | $1M+ | 300K | $3.85 | Jun 10, 2023 |
| Venker Eric | President & COO | SELL | $1K–$15K | 415 | $9.85 | May 26, 2023 |
| Venker Eric | President & COO | EXERCISE | $1K–$15K | 415 | $3.85 | May 26, 2023 |
| Venker Eric | President & COO | SELL | $1M+ | 239K | $9.23 | May 12, 2023 |
| Venker Eric | President & COO | EXERCISE | $500K+ | 239K | $3.85 | May 12, 2023 |
| Venker Eric | President & COO | EXERCISE | $500K+ | 150K | $3.85 | May 9, 2023 |
| Venker Eric | President & COO | SELL | $1M+ | 150K | $8.56 | May 9, 2023 |
| Venker Eric | President & COO | EXERCISE | $1M+ | 289K | $3.85 | May 4, 2023 |
| Venker Eric | President & COO | SELL | $1M+ | 289K | $8.40 | May 4, 2023 |
| Kumar Rakhi | Chief Accounting O… | SELL | $500K+ | 78K | $8.55 | May 4, 2023 |
| Kumar Rakhi | Chief Accounting O… | EXERCISE | $100K–$500K | 78K | $3.85 | May 4, 2023 |
| Kumar Rakhi | Chief Accounting O… | EXERCISE | $500K+ | 231K | $3.88 | Apr 29, 2023 |
| Kumar Rakhi | Chief Accounting O… | SELL | $1M+ | 231K | $8.56 | Apr 29, 2023 |
| Venker Eric | President & COO | EXERCISE | $500K+ | 222K | $3.85 | Apr 29, 2023 |
| Venker Eric | President & COO | SELL | $1M+ | 222K | $8.55 | Apr 29, 2023 |
| SVF Investments (UK) Ltd | 10% Owner | SELL | $1M+ | 12.0M | $8.00 | Mar 23, 2023 |
| Pulik Richard | CFO | SELL | $15K–$50K | 2K | $8.08 | Mar 4, 2023 |
| Ramaswamy Vivek | Director | SELL | $1M+ | 4.0M | $7.95 | Feb 22, 2023 |
| Venker Eric | President & COO | SELL | $100K–$500K | 24K | $8.02 | Jan 7, 2023 |
| Venker Eric | President & COO | SELL | $500K+ | 119K | $7.46 | Jan 5, 2023 |
| Venker Eric | President & COO | SELL | $1M+ | 145K | $7.03 | Dec 10, 2022 |
| SVF Investments (UK) Ltd | 10% Owner | SELL | $1M+ | 4.3M | $4.75 | Nov 16, 2022 |
| QVT Financial LP | Director | SELL | $1M+ | 5.7M | $4.75 | Nov 15, 2022 |
| Gold Daniel Allen | Director | SELL | $1M+ | 5.7M | $4.75 | Nov 15, 2022 |
| MANCHESTER KEITH S | Director | SELL | $1M+ | 3.9M | $4.75 | Nov 15, 2022 |
| Dexcel Pharma Technologies Ltd. | 10% Owner | BUY | $1M+ | 4.0M | $5.00 | Nov 14, 2022 |
| Gline Matthew | CEO | SELL | $50K–$100K | 19K | $4.40 | Oct 27, 2022 |
| Kumar Rakhi | Chief Accounting O… | SELL | $1K–$15K | 2K | $4.40 | Oct 27, 2022 |
| Venker Eric | President & COO | SELL | $50K–$100K | 16K | $4.40 | Oct 27, 2022 |
| Kumar Rakhi | Chief Accounting O… | SELL | $1K–$15K | 2K | $3.07 | Sep 27, 2022 |
| Venker Eric | President & COO | SELL | $50K–$100K | 17K | $3.07 | Sep 27, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 328 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 38.8M | $1M+ | SH |
| QVT Financial LP | 26.4M | $1M+ | SH |
| STATE STREET CORP | 17.4M | $1M+ | SH |
| SB INVESTMENT ADVISERS (UK) LTD | 16.4M | $1M+ | SH |
| Two Seas Capital LP | 9.8M | $1M+ | SH |
| Rubric Capital Management LP | 9.0M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 8.5M | $1M+ | SH |
| Patient Square Capital LP | 8.2M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 8.0M | $1M+ | SH |
| Assenagon Asset Management S.A. | 6.9M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 6.6M | $1M+ | SH |
| VIKING GLOBAL INVESTORS LP | 6.4M | $1M+ | SH |
| NORGES BANK | 5.2M | $1M+ | SH |
| Jefferies Financial Group Inc. | 3.5M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 3.4M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 3.4M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.2M | $1M+ | SH |
| Candriam S.C.A. | 2.5M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 2.4M | $1M+ | SH |
| Pictet Asset Management Holding SA | 2.3M | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Mar 6, 2026
10.3%
73.6M shares
SB Investment Advisers (UK) Limited
SC 13G/A · Feb 17, 2026
2.3%
16.4M shares
SC 13G/A · Feb 13, 2026
6.8%
48.4M shares
SC 13G/A · Feb 11, 2026
8.0%
55.5M shares
SC 13G/A · Feb 5, 2026
9.5%
65.8M shares
SC 13G/A · Nov 14, 2025
3.4%
23.6M shares
SB Investment Advisers (UK) Limited
SC 13G/A · Nov 14, 2025
5.8%
40.3M shares
SC 13G/A · Aug 14, 2025
5.0%
34.2M shares
SC 13G/A · Aug 14, 2025
4.3%
29.4M shares
SC 13G · Aug 7, 2025
5.5%
37.6M shares
SC 13G/A · Aug 6, 2025
8.2%
55.5M shares
SC 13G/A · May 15, 2025
11.6%
83.0M shares
SC 13G/A · May 15, 2025
11.2%
83.0M shares
SC 13G/A · May 15, 2025
6.4%
46.0M shares
SC 13G/A · Feb 14, 2025
9.2%
65.8M shares
SB Investment Advisers (UK) Limited
SC 13G/A · Feb 14, 2025
8.5%
62.1M shares
SC 13G/A · Nov 14, 2024
7.3%
54.1M shares
SC 13G/A · Nov 12, 2024
5.6%
41.7M shares
SC 13G · Nov 12, 2024
6.6%
49.1M shares
SC 13G/A · Nov 4, 2024
5.6%
41.7M shares
SC 13G/A · Apr 2, 2024
0.0%
0 shares
SC 13G/A · Mar 7, 2024
8.3%
66.7M shares
SC 13G/A · Feb 14, 2024
9.8%
81.5M shares
SC 13G/A · Feb 14, 2024
14.0%
112.5M shares
SC 13G/A · Feb 14, 2024
8.6%
69.4M shares
Dexcel Pharma Technologies Ltd.
SC 13G/A · Feb 14, 2024
0.6%
4.7M shares
SC 13G/A · Feb 13, 2024
9.8%
81.5M shares
SB Investment Advisers (UK) Limited
SC 13G/A · Feb 13, 2024
9.1%
73.0M shares
SC 13G/A · Feb 1, 2024
8.9%
71.3M shares
SC 13G/A · Jun 26, 2023
9.9%
75.2M shares
SC 13G/A · Feb 14, 2023
10.9%
81.8M shares
Dexcel Pharma Technologies Ltd.
SC 13G/A · Feb 14, 2023
0.6%
4.7M shares
SB Investment Advisers (UK) Limited
SC 13G/A · Feb 14, 2023
13.1%
95.0M shares
SC 13G/A · Feb 14, 2023
16.9%
122.5M shares
SC 13G/A · Feb 3, 2023
11.9%
86.4M shares
SC 13G · Feb 14, 2022
12.8%
0 shares
SC 13G · Feb 14, 2022
10.5%
74.4M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Feb 14, 2022
0.0%
0 shares
SC 13G · Feb 14, 2022
18.7%
129.4M shares
SB Investment Advisers (UK) Limited
SC 13G · Feb 14, 2022
14.4%
99.4M shares
Dexcel Pharma Technologies Ltd.
SC 13G · Feb 10, 2022
0.1%
644K shares
SC 13G · Feb 1, 2022
12.5%
86.4M shares